Want to hire this expert for a project? Request a quote for free.
Profile Details
Contact
USD 90 /hr
Hire Dr. Pari Jafari
Australia
USD 90 /hr
Scientific Advisor with PhD and 10+ years of global experience in Medical Device, Pharma, Clinical Research Organisation
Profile Summary
Subject Matter Expertise
Services
Consulting
Market research,
Feasibility study
Product development
Formulation & development
Writing
Journal article,
Review article,
Regulatory documents,
Educational content
Research
Internet research,
Evidence-based answers,
Secondary data compilation,
Literature search
Work Experience
Medical affairs and Clinical Science Professional/Medical Science Liaison
Medtronic
January 2018 - August 2020
Clinical Study Start-up Specialist
IQVIA
September 2017 - December 2017
Clinical Start-up and Regulatory Specialist (Medical writer/Medical Communication)
Syneos Health (Previously INCResearch)
September 2015 - August 2017
Clinical Research Professional (Study Manager for Pharmaceutical trials)
PRA Health Sciences
May 2013 - September 2015
Medical Science Liaison
Illawarra Health and Medical Research Institute
May 2011 - May 2013
Research Scientist
Wollongong University
January 2007 - June 2012
Senior Clinical Science Associate
Health Management and Economic Research Center - Isfahan University
September 2004 - September 2006
Education
PhD - Pharmacology
Wollongong University
January 2009 - June 2012
Master of Science in Medicinal and Pharmaceutical Chemistry - Research
Wollongong University
January 2007 - November 2008
University of Isfahan
Bachelor of Chemistry
October 2000 - June 2004
Certifications
- Certification details not provided.
Publications
JOURNAL ARTICLE
(2013). In vivo pharmacological evaluations of novel olanzapine analogues in rats: a potential new avenue for the treatment of schizophrenia . PloS one.
(2012). Novel olanzapine analogues presenting a reduced H1 receptor affinity and retained 5HT2A/D2 binding affinity ratio . BMC pharmacology.
(2012). Structural contributions of antipsychotic drugs to their therapeutic profiles and metabolic side effects . Journal of Neurochemistry.
(2006). Mathematical model for determination of colloid osmotic pressure: The role of albumin-globulin ratio. Journal of Research in Medical Science. Journal of Research in Medical Science.
CONFERENCE PAPER
(2012). Development of novel antipsychotic drugs with lower obesogenic effects. The 32nd Annual Meeting of The Australian Neuroscience Society.
CONFERENCE ABSTRACT
(2011). Development of novel antipsychotic drugs based on olanzapine that display reduced weight gain and metabolic side effects. 24th European Congress of Neuropsychopharmacology.
(2011). In vivo pharmacological evaluation of novel olanzapine analogues in rat: Potential novel antipsychotic drugs with lower obesogenic effect. 3rd European Conference on Schizophrenia Research.